| FAQ/Help |
| Calendar |
| Search |
| Today's Posts |
12-19-2013, 10:35 AM
|
#1 | ||
|
|||
|
Magnate
|
http://www.lctglobal.com/html/blob.p...lementId=20084
The withdrawal of the rat efficacy data does not in itself present a safety risk with regard to the use of NTCELL in humans . Nonetheless, as a precautionary measure LCT has placed a hold on any further patient recruitment into the human Phase I/IIa clinical study that is currently underway at Auckland City Hospital. This is to allow the company to work with the New Zealand medicines regulator (Medsafe) and the data safety monitoring board (DSMB) to fully understand the impact of the withdrawal of the rat efficacy data on the Phase I clinical trial |
||
|
 Reply With Quote
|
| Reply |
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| more on pig cell implant trial in N.Z. | Parkinson's Disease | |||
| new clinical trial with cell implants ijn new zealand | Parkinson's Disease | |||
| Joan - Trial Implant? | SCS & Pain Pumps | |||
| Let the journey begin! My SCS trial/implant with ANS St. Jude | SCS & Pain Pumps | |||
| Waiting to get my SCS trial/implant | SCS & Pain Pumps | |||
new zealand porcine implant trial suspended
Linear Mode
